Previous studies have reported differential plasma p‐tau217 and p‐tau181 levels in LBD with and without AD co‐pathology (defined by tau PET status using a temporal region of interest,30 CSF Aβ42/40,30, 64 and PiB SUVR65). This evidence concerns the gene MAPT and Alzheimer disease.